GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » T2 Biosystems Inc (NAS:TTOO) » Definitions » Shiller PE Ratio

T2 Biosystems (T2 Biosystems) Shiller PE Ratio : (As of Apr. 30, 2024)


View and export this data going back to 2014. Start your Free Trial

What is T2 Biosystems Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


T2 Biosystems Shiller PE Ratio Historical Data

The historical data trend for T2 Biosystems's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

T2 Biosystems Shiller PE Ratio Chart

T2 Biosystems Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

T2 Biosystems Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of T2 Biosystems's Shiller PE Ratio

For the Diagnostics & Research subindustry, T2 Biosystems's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


T2 Biosystems's Shiller PE Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, T2 Biosystems's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where T2 Biosystems's Shiller PE Ratio falls into.



T2 Biosystems Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

T2 Biosystems's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, T2 Biosystems's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-2.548/129.4194*129.4194
=-2.548

Current CPI (Dec. 2023) = 129.4194.

T2 Biosystems Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201403 -63.057 99.695 -81.858
201406 -51.100 100.560 -65.765
201409 -71.000 100.428 -91.496
201412 -45.000 99.070 -58.786
201503 -53.000 99.621 -68.853
201506 -54.000 100.684 -69.412
201509 -57.000 100.392 -73.481
201512 -56.000 99.792 -72.626
201603 -55.000 100.470 -70.847
201606 -58.000 101.688 -73.817
201609 -51.000 101.861 -64.798
201612 -48.000 101.863 -60.985
201703 -48.000 102.862 -60.393
201706 -50.000 103.349 -62.613
201709 -45.000 104.136 -55.926
201712 -51.000 104.011 -63.459
201803 -36.000 105.290 -44.250
201806 -32.000 106.317 -38.954
201809 -25.000 106.507 -30.378
201812 -35.000 105.998 -42.734
201903 -34.000 107.251 -41.028
201906 -35.000 108.070 -41.914
201909 -31.000 108.329 -37.035
201912 -29.000 108.420 -34.617
202003 -22.000 108.902 -26.145
202006 -9.000 108.767 -10.709
202009 -8.000 109.815 -9.428
202012 -6.692 109.897 -7.881
202103 -7.000 111.754 -8.106
202106 -8.000 114.631 -9.032
202109 -8.420 115.734 -9.416
202112 -7.000 117.630 -7.702
202203 -486.000 121.301 -518.527
202206 -510.000 125.017 -527.960
202209 -294.650 125.227 -304.516
202212 -141.000 125.222 -145.727
202303 -132.000 127.348 -134.147
202306 -8.000 128.729 -8.043
202309 -3.450 129.860 -3.438
202312 -2.548 129.419 -2.548

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


T2 Biosystems  (NAS:TTOO) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


T2 Biosystems Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of T2 Biosystems's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


T2 Biosystems (T2 Biosystems) Business Description

Traded in Other Exchanges
Address
101 Hartwell Avenue, Lexington, MA, USA, 02421
T2 Biosystems Inc provides rapid in vitro diagnostic tests to hospitals and laboratories. The company's core technology is T2 Magnetic Resonance (T2MR) technology, which can detect a variety of molecular targets directly from whole blood. T2MR technology enables the T2Dx system, which is fully automated from patient sample to result for its panels focused on bacterial and fungal infections that could cause sepsis, and its pipeline panel for Lyme disease.
Executives
Cr Group L.p. 10 percent owner 1000 MAIN STREET, SUITE 2500, HOUSTON TX 77002
Crg Partners Iii - Parallel Fund (a) L.p. 10 percent owner C/O CAPITAL ROYALTY L.P., 1000 MAIN STREET, SUITE 2500, HOUSTON TX 77002
Crg Partners Iii L.p. 10 percent owner 1000 MAIN STREET, SUITE 2500, HOUSTON TX 77002
Crg Partners Iii - Parallel Fund B (cayman) L.p. 10 percent owner 1000 MAIN STREET, SUITE 2500, HOUSTON TX 77002
Crg Partners Iii (cayman) Lev Aiv I L.p. 10 percent owner 1000 MAIN STREET, SUITE 2500, HOUSTON TX 77002
Crg Partners Iii (cayman) Unlev Aiv I L.p. 10 percent owner 1000 MAIN STREET, SUITE 2500, HOUSTON TX 77002
Michael Terrence Gibbs officer: General Counsel 12 STONEY BROOK RD., HOPKINTON MA 01748
John M Sprague officer: Chief Financial Officer 101 HARTWELL AVE., LEXINGTON MA 02421
Sperzel John J Iii director, officer: See Remarks 61 CRESTVIEW LANE, BRUNSWICK ME 04011
Brett A. Giffin officer: Chief Commercial Officer 101 HARTWELL AVE., LEXINGTON MA 02421
Alec Barclay officer: SVP, Operations 101 HARTWELL AVE., LEXINGTON MA 02421
Aparna Ahuja officer: Chief Medical Officer 101 HARTWELL AVENUE, LEXINGTON MA 02421
Laura Lee Adams director 101 HARTWELL AVE., LEXINGTON MA 02421
Anthony Pare officer: Chief Commercial Officer HAEMONETICS CORPORATION, 400 WOOD ROAD, BRAINTREE MA 02184
Thierry Bernard director 101 HARTWELL AVENUE, LEXINGTON MA 02421